Fact CheckerSign in

NCT05400499Recruiting

Deep Brain Stimulation for Visuomotor Function in Parkinson's Disease

Deep Brain Stimulation for Visuomotor Function in Parkinsons Disease

Source: ClinicalTrials.gov · Last updated 7 Jan 2026

Brief summary (registry, in English)

Inability to align and refocus the eyes on the objects at different depths, i.e., vergence impairment, frequently affects the quality of life in patients with Parkinson's disease. Our study aims to understand the location-specific effects of subthalamic region deep brain stimulation on vergence by integrating the patient-specific deep brain stimulation models and high-resolution eye-tracking measures. The knowledge gained will allow us to find the most beneficial stimulation location and parameters for improving binocular coordination and vergence while preserving the ability to treat motor symptoms in Parkinson's disease.

Status (registry)
Recruiting
Study type
Observational
Enrollment
40 (estimated)
First submitted
27 May 2022
Start date
4 Oct 2022
Primary completion date
30 Jun 2026
Lead sponsor
VA Office of Research and Development
NCT number
NCT05400499

What you commit to

  • Study type: Observational
  • Planned participants: 40
  • From 4 Oct 2022 to the primary completion date, 30 Jun 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous surgical therapy for Parkinson's disease (other than DBS)

Other illness

  • Dementia

Other

  • Clinically significant untreated depression or anxiety
  • Clinical features suggestive of atypical parkinsonism

Who the study is looking for

  • Parkinson's disease with bilateral STN DBS
  • Availability of pre-operative MR images (with a T1-weighted, gradient-echo sequence) and ability to get post-operative MRI or CT scans
  • Hoehn and Yahr stage 2-4 when off medication, and a stable antiparkinsonian medication regimen and DBS parameter settings

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Louis Stokes VA Medical Center, Cleveland, OH
Coordinator of this site? Confirm its status
ClevelandUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.